Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Briacell Therapeutics Corp 235 15th Street Suite 300 WEST VANCOUVER A1 V7T 2X1 CAN

https://briacell.com Employees: 22 P: 604-921-1810 F: 424-245-3719

Sector:

Medical

Description:

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the `BriaVax` vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 8,082
Enterprise Value, $K -2,408
Shares Outstanding, K 1,884
Float, K 1,776
% Float 94.27%
Short Interest, K 102
Short Float 5.44%
Days to Cover 1.64
Short Volume Ratio 0.44
% of Insider Shareholders 5.73%
% of Institutional Shareholders 15.42%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -26,310 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,200 K
EBIT, $ -30,370 K
EBITDA, $ -30,260 K

Growth:

1-Year Return -92.57%
3-Year Return -99.59%
5-Year Return -99.45%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 92.02%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.35 on 12/11/25
Next Earnings Date 03/11/26
Earnings Per Share ttm -44.05
EPS Growth vs. Prev Year 86.81%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 08/25/25

BCTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -275.06%
Return-on-Assets % -188.44%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.90
Book Value/Share 4.97
Interest Coverage -3.48
60-Month Beta 1.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar